Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2021-09-17 00:00:00 ET · period of report 2021-09-15 · accession 0001209191-21-056604 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-17 | 2021-09-15 | KYNB | KEARNS THOMAS F JR | Dir | S - Sale | $11.58 | -13.1K | 39.8K | -25% | -$151.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-15 | S | D | 13,100 | $11.58 | 39,764 | D | — | — | (F1) These shares were sold in multiple transactions on the reported date with prices ranging from $11.46 to $11.615 resulting in a weighted average price of $11.5807. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction. |